R Hettle1, J Borrill2, G Suri1, J Wulff1. Show Affiliations » 1. PAREXEL Consulting, London, UK. 2. AstraZeneca, Macclesfield, UK.
Abstract
Entities: Chemical Disease
Year: 2014 PMID: 27202324 DOI: 10.1016/j.jval.2014.08.2341
Source DB: PubMed Journal: Value Health ISSN: 1098-3015 Impact factor: 5.725